Microsoft will soon have millions of lines of new code written to replace C and C++. A combination of AI, algorithms, and ...

Microsoft is taking an impressive step in modernizing its biggest codebases and will eliminate all C/C++ code by the end of ...

Figuring out how to structure your days so they're as productive as possible is a challenge, which is why there are so many different techniques for doing it, though they're all best suited to ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

PORTSMOUTH, N.H.--(BUSINESS WIRE)-- Albany International Corp. (NYSE: AIN) announced today that it is exploring strategic alternatives for its structures assembly business, including a potential sale ...

Albany International Initiates Review of Strategic Alternatives for Structures Assembly Business; Announces Loss Reserve Adjustment for CH-53K Program; Schedules Earnings Release Date Third-Quarter ...

ChatGPT adoption is accelerating at a scale rarely seen in technology. By mid-2025, around 700 million people worldwide were using it every week, sending 18 billion messages, which is roughly 10% of ...

OKLAHOMA CITY (KFOR) – Artificial intelligence is reportedly making its way into a traditional Medicare pilot program that six states, including Oklahoma, will test out. It has to do with patients ...